Duloxetine Effective at Reducing Chemotherapy Pain
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
Sublingual opioid sufentanil NanoTab PCA is superior to intravenous PCA morphine for post-surgical acute pain management.
The FDA announced the approval of InsighTec’s ExAblate magnetic resonance imaging-guided focused ultrasound thermoablation system, the first device approved in the US for pain palliation in patients with bone metastasis.
The FDA has approved a noninvasive magnetic resonance imaging-guided focused ultrasound (MRIgFU) ablation therapy for palliation of painful metastatic bone tumors among patients who cannot undergo or have not responded to palliative radiotherapy.
Pain management is important for cancer patients during therapy and sometimes after treatment is completed—not just at the end of life.
Reviews several of the opioid pain relief medications, in which transdermal delivery has become a popular mechanism for pain relief.
Reviews the growing body of evidence of the role of acupuncture in pain management in cancer and palliative care.